Table 7. Overall performance of all example cases.
| 40X cycling | 63X cycling | 40X sporulating |
0 nM |
3 nM |
6 nM |
9 nM |
12 nM |
Bright Field |
|
|---|---|---|---|---|---|---|---|---|---|
| Total # of segmented cells | 156 | 101 | 162 | 66 | 64 | 57 | 44 | 33 | 169 |
| Total number of segmentation events | 6957 | 5030 | 16199 | 9903 | 13122 | 13030 | 10134 | 6908 | 11116 |
| Fraction of accurate segmentations | 99.4% | 99.4% | 99.4% | 99.4% | 97.9% | 97.7% | 99.9% | 97.6% | 92.0% |
| Fraction of minor segmentation errors | 0.6% | 0.6% | 0.6% | 0.3% | 0.4% | 0.7% | 0.1% | 1.8% | 6.9% |
| Fraction of major segmentation errors | 0% | 0% | 0% | 0.3% | 1.7% | 1.6% | 0% | 0.6% | 1.1% |
| Fraction of individual time-series without any errors | 92.9% | 95.0% | 90.7% | 90.9% | 81.25% | 84.2% | 93.2% | 78.8% | 63.3% |
| # fields of view | 2 | 3 | 2 | 3 | 2 | 3 | 3 | 3 | 2 |
0, 3, 6, 9, 12 nM refer to α-factor concentrations used for treating cln1cln2cln3 cells. #: Number